Studies: Bone drugs may help prevent breast cancer

December 10, 2009 By MARILYNN MARCHIONE , AP Medical Writer

(AP) -- New results from a large women's health study suggest that bone-building drugs such as Fosamax and Actonel might help prevent breast cancer.

Women who already were taking these medicines when the study began were nearly one-third less likely to develop over the next seven years. That's compared to women who were not on such pills.

The study by itself is not proof that these drugs can prevent cancer. More definitive studies should give a clearer picture in a year or two. Until then, doctors say women should only take these drugs if they have osteoporosis or other bone problems.

However, doctors are excited because it fits with other research last year that found one of these bisphosphonate drugs cut the chances that cancer would come back in women already treated for the disease.

"Now we're actually looking at this in the general population - healthy women who have never had breast cancer. And it looks like it's protective in those as well," said Dr. Peter Ravdin of the University of Texas Health Science Center at San Antonio.

"There's a strengthening story here," he said. "This is very promising."

The new results were presented Thursday at the San Antonio Breast Cancer Symposium. They come from more than 151,000 participants in the Women's Health Initiative, a study known for revealing previously unrecognized risks from taking estrogen and progestin pills after menopause.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Related Stories

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.